André L.S. Santos
Microbial infectious diseases continue to be one of the greatest health problems worldwide, afflicting millions of people annually. Due to the diminutive arsenal of efficient antimicrobial agents and the frequent appearance of resistance to the drugs in current use, which consequently reduce the means to treat infected patients, there is a very urgent and continuous need to develop new chemotherapeutic drugs. This paper presents a personal opinion on this theme and some beneficial examples obtained and published by my research group along the last five years.
Compartilhe este artigo
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Hindi 